CAN INHIBITION OF HORMONE SECRETION BE ASSOCIATED WITH ENDOCRINE TUMOUR SHRINKAGE?
- 1 December 1983
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 322 (8365-8366) , 1501
- https://doi.org/10.1016/s0140-6736(83)90847-4
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Cancer: Oncogenes and growth factorsNature, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Bromocriptine in management of large pituitary tumours.BMJ, 1982
- The Effect of Somatostatin Analogs on Secretion of Growth, Pancreatic, and Gastrointestinal Hormones in ManJournal of Clinical Endocrinology & Metabolism, 1981
- SUPPRESSION OF PANCREATIC ENDOCRINE TUMOUR SECRETION BY LONG-ACTING SOMATOSTATIN ANALOGUEThe Lancet, 1979
- Regression of pituitary tumors, a possible effect of bromergocryptineThe American Journal of Medicine, 1979
- Metabolic Clearance and Plasma Half-Disappearance Time of Exogenous Somatostatin in Man*Journal of Clinical Endocrinology & Metabolism, 1979